Kyowa Kirin Co., Ltd. · TSE:4151

Kyowa Kirin — Kyowa Hakko Kogyo — FY2006 Earnings Presentation

41 slides from Kyowa Kirin's earnings presentation, 2007

  1. Slide 1: Sep IRB

    Sep IRB

  2. Slide 2: Sep IRB

    Sep IRB

  3. Slide 3: Slide 3

  4. Slide 4: ep mle

    ep mle

  5. Slide 5: Slide 5

  6. Slide 6: Sep BARB

    Sep BARB

  7. Slide 7: Se BARB

    Se BARB

  8. Slide 8: wip FE

    ) ee ee wip FE

  9. Slide 9: Sep BARB

    Sep BARB

  10. Slide 10: 50 280 4 34 72 241 254 100 16 50 22 22 50 36

    350 8 200 9 11 9 9 300 29 11 9 33 150 250 26 53 200 12 100 150 280 4 34 72 241 254 100 16 50 22 22 50 36 40 27 0 0 2005/03 2006/03 2007/03 2005/03 2006/03 2007/03

  11. Slide 11: Gp me

    Gp me

  12. Slide 12: Biogen-IDEC BIOKYOWA USA , Mo) Shanghai Kyowa Amino Acid (China, Shanghai

    Biogen-IDEC BIOKYOWA USA , Mo) Medarex Shanghai Kyowa Amino Acid (China, Shanghai MedImmune Igeneon (Aphton) Genentech R&D R&D KPI (USA, N.J.) Kyowa Hakko UK (UK) BioWa (USA, N.J.)

  13. Slide 13: Pep IRS

    Pep IRS

  14. Slide 14: Slide 14

  15. Slide 15: WNr

    WNr Gp RES

  16. Slide 16: MDS 8th International Congress of PD and Movement Disorders

    – – – – MDS 8th International Congress of PD and Movement Disorders June 13 to 17, 2004 in Rome, Italy.

  17. Slide 17: mg/ mg/ mg/

    \ 0 mg/ mg/ mg/ Sep IRB

  18. Slide 18: Sep IRB

    Sep IRB

  19. Slide 19: Slide 19

  20. Slide 20: Sep IRB

    Sep IRB

  21. Slide 21: Se BARB

    Tl Se BARB

  22. Slide 22: KW-0761 MOA

    KW-0761 MOA Th2 cell Antigen-CCR4 IL-4, IL-13 IL-5 B cell Eosinophil IgE Mast cell Inflammatory mediators Humoral immunity Allergy

  23. Slide 23: US$900M - 1,100M

    2020 @. [==> US$900M - 1,100M Gp Ee

  24. Slide 24: 9 9

    9 9 9 9 9 9 9 9 9 9

  25. Slide 25: Sep IRB

    Sep IRB

  26. Slide 26: POTELLIGENT ADCC comparison

    POTELLIGENT 80 POTELLIGENT Xencor ADCC (%) 60 Xencor Genentech 40 20 0 0.0001 100 0.01 1 IgG1 (µg/ml)

  27. Slide 27: Sep IRB

    Sep IRB

  28. Slide 28: Zep BRB

    Zep BRB

  29. Slide 29: Slide 29

  30. Slide 30: Sep IRB

    Sep IRB

  31. Slide 31: 4000 3000 0 53 7 40 779 858 830 11 23 880 16 68

    4000 400 222 182 160 15 140 15 444 424 460 16 30 3000 430 300 53 7 40 779 858 830 11 23 880 16 68 95 200 45 45 2000 577 574 680 720 40 50 1000 100 181 1564 1495 160 1330 142 135 1270 0 0 2005/03 2006/03 2007/03 2008/03 2005/03 2006/03 2007/03 2008/03 ‹ / / / /

  32. Slide 32: > Re

    > Re

  33. Slide 33: Sep IRB

    Sep IRB

  34. Slide 34: High-quality products worldwide

    High-qualit ‘products wortdwide wip FE

  35. Slide 35: 3800 ‹ 3600 3400 3200 3000 2004/03 2005/03 2006/03 2007/03 60 320 280 240

    3800 ‹ 3600 3400 3200 3000 2004/03 2005/03 2006/03 2007/03 360 320 280 240 200 2004/03 2005/03 2006/03 2007/03

  36. Slide 36: Slide 36

  37. Slide 37: Se BARB

    Se BARB

  38. Slide 38: Slide 38

  39. Slide 39: eco @

    eco @ > Re

  40. Slide 40: wip FE

    cS) wip FE

  41. Slide 41: Sep IRB

    Sep IRB

Kyowa Hakko Kogyo — FY2006 Earnings Presentation on 6ix